United Kingdom - English - myHealthbox

south devon healthcare nhs foundation trust - metaraminol - solution for injection or infusion - 10mg/ml - adrenergic and dopaminergic agent - for the treatment of acute hypotension due to loss of vasoconstrictor tone as may occur during spinal anaesthesia and as an adjunct to accepted remedial procedures.

New Zealand - English - Medsafe (Medicines Safety Authority)

phebra nz limited - metaraminol tartrate 0.95 mg/ml equivalent to metaraminol 0.5 mg/ml - solution for injection - 3 mg/6ml - active: metaraminol tartrate 0.95 mg/ml equivalent to metaraminol 0.5 mg/ml excipient: sodium chloride sodium metabisulfite water for injection - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.

New Zealand - English - Medsafe (Medicines Safety Authority)

phebra nz limited - metaraminol tartrate 0.95 mg/ml equivalent to metaraminol 0.5 mg/ml - solution for injection - 5 mg/10ml - active: metaraminol tartrate 0.95 mg/ml equivalent to metaraminol 0.5 mg/ml excipient: sodium chloride sodium metabisulfite water for injection - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - metaraminol tartrate 10 mg/ml - solution for injection - 10 mg/ml - active: metaraminol tartrate 10 mg/ml excipient: methyl hydroxybenzoate propyl hydroxybenzoate sodium bisulfite sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

phebra nz limited - metaraminol tartrate 18.96 mg/ml equivalent to metaraminol 10 mg - solution for injection - 10 mg/ml - active: metaraminol tartrate 18.96 mg/ml equivalent to metaraminol 10 mg excipient: sodium chloride sodium hydroxide sodium metabisulfite tartaric acid water for injection - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - metaraminol tartrate - solution for injection - 10mg/1ml

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

verve human care laboratories, india - metaraminol - solution for injection - 10 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate - solution for infusion - 0 percent volume/volume - solutions affecting the electrolyte balance; electrolytes

Malta - English - Malta Medicines Authority

baxter healthcare limited - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - calcium chloride dihydrate 0.27 gram(s)/litre ; potassium chloride 0.4 gram(s)/litre ; sodium chloride 6 gram(s)/litre ; sodium lactate 3.2 gram(s)/litre - blood substitutes and perfusion solutions

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - metoprolol tartrate - tablets - 50 milligram